Literature DB >> 8698482

Purification and biochemical characterization of a 65-kilodalton mannoprotein (MP65), a main target of anti-Candida cell-mediated immune responses in humans.

M J Gomez1, A Torosantucci, S Arancia, B Maras, L Parisi, A Cassone.   

Abstract

A 65 kDa-constituent (MP65) of a whole-cell mannoprotein (MP) fraction of Candida albicans was purified by immunoaffinity chromatography with monoclonal antibodies directed against periodate-insensitive, protease-sensitive MP epitopes, putatively polypeptide in nature. These antibodies were obtained by immunization of mice with concanavalin A bead-coupled, low-glycosylated MP from hyphal cells of C. albicans grown in the presence of a subinhibitory dose of tunicamycin. The immunoaffinity-purified MP65 molecule had a pI of 4.1 and a protein/polysaccharide ratio of 1.8:1. It was resistant to hydrolysis by endoglycosidase H, endoglycosidase F, or N-glycoffanases but still reactive with concanavalin A. The polysaccharide moiety of MP65 was composed exclusively of mannose and glucose at a ratio of 12.7 to 1. The protein moiety showed numerous potential O-glycosidic linkage sites as suggested by the high proportion of serine and threonine (together accounting for more than 20% of the total amino acid composition) and susceptibility to diluted alkali. This treatment and digestion with alpha-mannosidase caused a reduction in the MP65 molecular mass to around 54 kDa. The N-terminal sequence of MP65 protein moiety was rich in alanine and valine (7 of 13 amino acids) and did not show any significant homology with deposited sequences in data banks. Purified MP65, at doses of a few nanograms, induced extensive T-cell proliferation of human peripheral blood mononuclear cells. This proliferation was specifically inhibited, in a dose-response fashion, by the antigen-binding fragment of the monoclonal antibody used for immunoaffinity purification. Overall, these results highlight biochemical and molecular details of MP65, a main target of human T-cell response to C.albicans.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8698482      PMCID: PMC174113          DOI: 10.1128/iai.64.7.2577-2584.1996

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  45 in total

1.  Identification of wall-specific antigens synthesized during germ tube formation by Candida albicans.

Authors:  M Casanova; M L Gil; L Cardeñoso; J P Martinez; R Sentandreu
Journal:  Infect Immun       Date:  1989-01       Impact factor: 3.441

2.  Identification of C3d receptors on Candida albicans.

Authors:  R A Calderone; L Linehan; E Wadsworth; A L Sandberg
Journal:  Infect Immun       Date:  1988-01       Impact factor: 3.441

3.  An iC3b receptor on Candida albicans: structure, function, and correlates for pathogenicity.

Authors:  B J Gilmore; E M Retsinas; J S Lorenz; M K Hostetter
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

4.  Production and characterisation of a monoclonal antibody to a cell-surface, glucomannoprotein constituent of Candida albicans and other pathogenic Candida species.

Authors:  A Cassone; A Torosantucci; M Boccanera; G Pellegrini; C Palma; F Malavasi
Journal:  J Med Microbiol       Date:  1988-12       Impact factor: 2.472

5.  "Western blotting": electrophoretic transfer of proteins from sodium dodecyl sulfate--polyacrylamide gels to unmodified nitrocellulose and radiographic detection with antibody and radioiodinated protein A.

Authors:  W N Burnette
Journal:  Anal Biochem       Date:  1981-04       Impact factor: 3.365

6.  Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome.

Authors:  R S Klein; C A Harris; C B Small; B Moll; M Lesser; G H Friedland
Journal:  N Engl J Med       Date:  1984-08-09       Impact factor: 91.245

Review 7.  Candida infections: an overview.

Authors:  F C Odds
Journal:  Crit Rev Microbiol       Date:  1987       Impact factor: 7.624

8.  Proliferation of human peripheral blood mononuclear cells induced by Candida albicans and its cell wall fractions.

Authors:  C M Ausiello; G C Spagnoli; M Boccanera; I Casalinuovo; F Malavasi; C U Casciani; A Cassone
Journal:  J Med Microbiol       Date:  1986-11       Impact factor: 2.472

9.  Characterization of Candida albicans cell wall antigens with monoclonal antibodies.

Authors:  J Ponton; A Marot-Leblond; P A Ezkurra; B Barturen; R Robert; J M Senet
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Mannan-specific and mannan-induced T-cell suppressive activity in patients with chronic mucocutaneous candidiasis.

Authors:  A Durandy; A Fischer; F Le Deist; E Drouhet; C Griscelli
Journal:  J Clin Immunol       Date:  1987-09       Impact factor: 8.317

View more
  29 in total

1.  Protective effect of fungal extracellular vesicles against murine candidiasis.

Authors:  Gabriele Vargas; Leandro Honorato; Allan Jefferson Guimarães; Marcio L Rodrigues; Flavia C G Reis; André M Vale; Anjana Ray; Joshua Daniel Nosanchuk; Leonardo Nimrichter
Journal:  Cell Microbiol       Date:  2020-07-22       Impact factor: 3.715

2.  Biochemical and immunological characterization of MP65, a major mannoprotein antigen of the opportunistic human pathogen Candida albicans.

Authors:  M J Gomez; B Maras; A Barca; R La Valle; D Barra; A Cassone
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

Review 3.  Cell wall and secreted proteins of Candida albicans: identification, function, and expression.

Authors:  W L Chaffin; J L López-Ribot; M Casanova; D Gozalbo; J P Martínez
Journal:  Microbiol Mol Biol Rev       Date:  1998-03       Impact factor: 11.056

4.  A 70-kilodalton recombinant heat shock protein of Candida albicans is highly immunogenic and enhances systemic murine candidiasis.

Authors:  C Bromuro; R La Valle; S Sandini; F Urbani; C M Ausiello; L Morelli; C Fé d'Ostiani; L Romani; A Cassone
Journal:  Infect Immun       Date:  1998-05       Impact factor: 3.441

5.  Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats.

Authors:  F De Bernardis; M Boccanera; D Adriani; E Spreghini; G Santoni; A Cassone
Journal:  Infect Immun       Date:  1997-08       Impact factor: 3.441

6.  Mannoproteins from Cryptococcus neoformans promote dendritic cell maturation and activation.

Authors:  Donatella Pietrella; Cristina Corbucci; Stefano Perito; Giovanni Bistoni; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

7.  Mannoprotein from Cryptococcus neoformans promotes T-helper type 1 anticandidal responses in mice.

Authors:  Donatella Pietrella; Rosanna Mazzolla; Patrizia Lupo; Lucia Pitzurra; Maria Jesus Gomez; Robert Cherniak; Anna Vecchiarelli
Journal:  Infect Immun       Date:  2002-12       Impact factor: 3.441

8.  New approach for diagnosis of candidemia based on detection of a 65-kilodalton antigen.

Authors:  Rodrigo Berzaghi; Arnaldo Lopes Colombo; Antonia Maria de Oliveira Machado; Zoilo Pires de Camargo
Journal:  Clin Vaccine Immunol       Date:  2009-09-23

9.  Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine.

Authors:  Carla Bromuro; Antonella Torosantucci; Paola Chiani; Stefania Conti; Luciano Polonelli; Antonio Cassone
Journal:  Infect Immun       Date:  2002-10       Impact factor: 3.441

10.  Effect of tunicamycin on Candida albicans biofilm formation and maintenance.

Authors:  Christopher G Pierce; Derek P Thomas; José L López-Ribot
Journal:  J Antimicrob Chemother       Date:  2008-12-20       Impact factor: 5.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.